HBIOHARVARD BIOSCIENCE INC

Nasdaq harvardbioscience.com


$ 3.86 $ 0.00 (0 %)    

Thursday, 02-May-2024 15:59:30 EDT
QQQ $ 429.07 $ 5.38 (1.28 %)
DIA $ 382.31 $ 3.34 (0.88 %)
SPY $ 505.01 $ 4.68 (0.94 %)
TLT $ 88.87 $ 0.38 (0.43 %)
GLD $ 213.12 $ -0.66 (-0.31 %)
$ 3.82
$ 3.90
$ 0.00 x 0
$ 0.00 x 0
$ 3.80 - $ 3.90
$ 3.44 - $ 6.28
84,969
na
165.79M
$ 1.39
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-07-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 04-26-2023 03-31-2023 10-Q
5 03-09-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-04-2022 03-31-2022 10-Q
9 03-11-2022 12-31-2021 10-K
10 11-05-2021 09-30-2021 10-Q
11 08-06-2021 06-30-2021 10-Q
12 05-07-2021 03-31-2021 10-Q
13 03-12-2021 12-31-2020 10-K
14 11-06-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-08-2020 03-31-2020 10-Q
17 03-16-2020 12-31-2019 10-K
18 11-08-2019 09-30-2019 10-Q
19 08-08-2019 06-30-2019 10-Q
20 05-08-2019 03-31-2019 10-Q
21 03-18-2019 12-31-2018 10-K
22 11-01-2018 09-30-2018 10-Q
23 08-02-2018 06-30-2018 10-Q
24 05-10-2018 03-31-2018 10-Q
25 03-16-2018 12-31-2017 10-K
26 11-02-2017 09-30-2017 10-Q
27 08-03-2017 06-30-2017 10-Q
28 05-08-2017 03-31-2017 10-Q
29 03-17-2017 12-31-2016 10-K
30 11-03-2016 09-30-2016 10-Q
31 08-04-2016 06-30-2016 10-Q
32 05-16-2016 03-31-2016 10-Q
33 04-29-2016 12-31-2015 10-K
34 11-05-2015 09-30-2015 10-Q
35 08-06-2015 06-30-2015 10-Q
36 05-07-2015 03-31-2015 10-Q
37 03-12-2015 12-31-2014 10-K
38 11-06-2014 09-30-2014 10-Q
39 08-07-2014 06-30-2014 10-Q
40 05-08-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 harvard-bioscience-q4-adj-eps-004-misses-005-estimate-sales-2815m-miss-2911m-estimate

Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of Adj $0.04 per share which missed the analyst consensus estimate...

 earnings-scheduled-for-march-7-2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

 harvard-bioscience-to-showcase-latest-solutions-for-preclinical-and-organoid-applications-at-society-of-toxicology-meeting

Harvard Bioscience, Inc. (NASDAQ:HBIO) today announced that it will be showcasing its latest product innovations at the Society...

 harvard-bioscience-q3-adjusted-eps-001-misses-004-estimate-sales-2536m-miss-2802m-estimate

Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of ...

 earnings-scheduled-for-november-7-2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

 harvard-bioscience-and-etisense-announce-agreement-for-supply-and-distribution-of-decro-miniature-telemetry-jacket-platform-for-pre-clinical-research

Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI) Expands...

 harvard-bioscience-expects-fy23-revenues-of-116m-120m-consensus-12076m

This expected growth anticipates an approximate 4 percentage point headwind from discontinued products.

 harvard-bioscience-q2-adj-eps-004-misses-005-estimate-sales-2880m-miss-2950m-estimate

Harvard Bioscience (NASDAQ:HBIO) reported quarterly adj earnings of $0.04 per share which missed the analyst consensus estimate...

 earnings-scheduled-for-august-8-2023

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly earnings at $0.21 per share o...

 benchmark-reiterates-speculative-buy-on-harvard-bioscience-maintains-7-price-target

Benchmark analyst Bruce Jackson reiterates Harvard Bioscience (NASDAQ:HBIO) with a Speculative Buy and maintains $7 price ta...

 harvard-bioscience-set-to-join-russell-2000-and-3000-indexes

Harvard Bioscience, Inc. (NASDAQ:HBIO) (the “Company”) today announced that it is set to join the Russell 2000® and Russell 300...

 benchmark-maintains-buy-on-harvard-bioscience-raises-price-target-to-7

Benchmark analyst Bruce Jackson maintains Harvard Bioscience (NASDAQ:HBIO) with a Buy and raises the price target from $4 to...

 keybanc-maintains-overweight-on-harvard-bioscience-raises-price-target-to-7

Keybanc analyst Paul Knight maintains Harvard Bioscience (NASDAQ:HBIO) with a Overweight and raises the price target from $5...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION